Clinical Trials Browser

Phase 4 × Lymphoma, Large B-Cell, Diffuse × selinexor × Clear all

NCT05786989 2023-03-28

Selinexor Combined With R-GemOx as Second-line Treatment in Patients With Diffuse Large B-cell Lymphoma

Phase 4 Unknown

Lymphoma, Large B-Cell, Diffuse